XI SYMPOSIUM CURRENT THEMES IN BIOLOGICAL RESEARCH
"MOLECULAR TARGETS IN CANCER THERAPY"

2 de Noviembre 1999.
Lugar: Instituto de Investigaciones Biomédicas. Salón de Actos. Arturo Duperier 4. 28029 Madrid.

ORGANIZA

Centro de Investigación Básica de MERCK, SHARP & DOHME de España (CIBE-SPAIN)

PROGRAMA

Organizer: Fernando Peláez
Chairmen: Mariano Barbacid
Juan Carlos Lacal
Wellcome remarks: Juan Bernal Carrasco (Instituto de Investigaciones Biomédicas "Alberto Sols", Madrid)

… 9:30-9:45
Fernando Peláez (Centro de Investigación Básica. Merck Sharp & Dohme de España)
Introduction.

… 9:45-10:30
Mariano Barbacid (Centro Nacional de Investigaciones Oncológicas Carlos III, Madrid)
Cell cycle and cancer

… 10:30-11:15
Theresa Williams (Merck Research Laboratories. West Point, PA)
Preclinical studies of Farnesyltransferase inhibitors

… 11:15-11:45 Coffee break

… 11:45-12:30
Jorge Moscat (Centro de Biología Molecular "Severo Ochoa", Madrid)
Novel components of the PKC/NF-kB pathway as targets for anti-cancer drugs

… 12:30-13:15
Axel Ullrich (Max Planck Institute of Biochemistry. Martinsried, Germany)
Receptor Tyrosine Kinases as targets for cancer therapy

… 13:15-14:30 Lunch

… 14:30-15:15
Juan Carlos Lacal (Instituto de Investigaciones Biomédicas "Alberto Sols", Madrid)
In vivo antitumor activity of Choline Kinase inhibitors: a novel target for anticancer drug discovery.

… 15:15-16:00
María Blasco (Centro Nacional de Biotecnología, Madrid)
Telomerase, cancer and ageing.

… 16:00-16:15 Coffee break

… 16:15-17:00
José Baselga (Hospital Vall d´Hebrón, Barcelona)
Clinical implications of new molecular targets: Herceptin and beyond

… 17:00-17:15
Juan Carlos Lacal
Concluding remarks

SECRETARIA CIENTIFICA

Rosario Perona
Instituto de Investigaciones Biomédicas
Arturo Duperier,4. Madrid
Ph: 34-91-5854652
Fax: 34-91-5854587
Mail: RPerona@biomed.iib.uam.es